Crystal structures and solution studies of two novel Zinc(II) complexes of a proton transfer compound obtained from 2,6-pyridinedicarboxylic acid and 1,10-phenanthroline: Observation of strong intermolecular hydrogen bonds

被引:96
作者
Moghimi, A
Sheshmani, S
Shokrollahi, A
Shamsipur, M
Kickelbick, G
Aghabozorg, H
机构
[1] Teacher Training Univ, Dept Chem, Tehran, Iran
[2] Imam Hossein Univ, Dept Chem, Tehran, Iran
[3] Islamic Azad Univ, Shahr Rey Branch, Dept Chem, Tehran, Iran
[4] Razi Univ, Dept Chem, Kermanshah, Iran
[5] Vienna Univ Technol, Inst Mat Chem, Vienna, Austria
来源
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE | 2005年 / 631卷 / 01期
关键词
zinc; 16-pyridinedicarboxylic acid; 1,10-pheilanthroline-; hydrogen bonds; solution studies;
D O I
10.1002/zaac.200400280
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The proton transfer compound LH(2), (phenH(+))(2)(pydc(2-)), has been prepared from 1,10-phenanthroline, phen, and 2,6-pyridinedicarboxylic acid, (dipicolinic acid), pydcH(2). Characterization was performed using solution and solid phase CP/MAS (13)C NMR and IR spectroscopy The reactions of this adduct with ZnSO(4).-7H(2)O and Zn(NO(3))(2).4H(2)O give the complexes, [Zn(pydc)(2)][Zn(phen)(2)(H(2)O)(2)].7H(2)O (1) and [Zn(phen)(3)]4(H(Hpydc)(2))(NO(3))(7).26H(2)O (2), respectively. These complexes were characterized by (1)H and (13)C NMR spectroscopy and single crystal X-ray analysis. The complexes crystallize in the triclinic space group P (1) over bar with Z = 2. The unit cell dimensions for complex 1 and 2 are: a = 9.9838(9) Angstrom, b = 14.7483(13) Angstrom, c = 14.8365(13) Angstrom and a = 12.640(4) Angstrom, b 15.855(5) Angstrom, c = 21.830(7) Angstrom, respectively. In complex 1 (pydc(2-)) and phen, are tri- and bidentate ligands, respectively, and an anionic [Zn(pydc(2)](2-) and cationic [Zn(phen)(2)(H(2)O)(2)](2+) complex are formed simultaneously. In cornplex 2, three phen participate in complexation leaving hydrogenbis(pyridine-2-carboxylate), (H(HpydC)(2))(-) as a supramolecular anion. The fragments (H(HpydC)(2))(-), 7 NO(3)(-), and 26 H(2)O in complex 2 are joined together by extensive and strong H-bonding; therefore, the structure is composed of [Zn(phen)(3)](4)(8+), and an anionic hydrogen bond supramolecular assembly with the formula, {(H(Hpydc)(2)(NO(3))(7))(8-).26H(2)O}(n). The anionic species (H(Hpydc)(2))(-) has a special position at the inversion center, as well as one of the NO(3)(-) anions, which is disordered over the inversion center. Most of the hydrogen bonds in complex 2 represent strong H-bonding. The protonation constants of the building blocks of the pydc-phen adduct, the equilibrium constants for the reaction of (pydc(2-)) With phenanthroline and the stoichiometry and stability of the Zn(11) complex with LH(2) on aqueous solution were determined by potentiometric pH titration. The solution study results support self-association between (pydc(2-)) and (phenH(+)) with a stoichiornetry for the Zn(II) complex similar to that observed for the isolated crystalline complex.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 44 条
[31]  
Ranjbar M, 2002, POL J CHEM, V76, P785
[32]   Crystal structure of Bi(III) complex of a pyridine containing self-assembling system [J].
Ranjbar, M ;
Aghabozorg, H ;
Moghimi, A ;
Yanovsky, A .
ANALYTICAL SCIENCES, 2001, 17 (12) :1469-1470
[33]  
Schwarzenbach G., 1969, COMPLEXOMETRIC TITRA
[34]  
Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR
[35]  
Sheldrick G.M., 1996, SADABS VERSION 2008
[36]  
SIGEL H, 1972, J INORG CHEMN, V12, P1198
[37]  
SKURAI H, 1995, BIOCHEM BIOPH RES CO, V206, P133
[38]   Molecular cocrystals of carboxylic acids:: the preparation of the 1:1 proton-transfer compounds of creatinine with a series of aromatic acids and the crystal structure of that with pyrazine-2,3-dicarboxylic acid [J].
Smith, G ;
White, JM .
AUSTRALIAN JOURNAL OF CHEMISTRY, 2001, 54 (02) :97-100
[39]   Cooperative assistance in a very short O-H•••O hydrogen bond.: Low-temperature X-ray crystal structures of 2,3,5,6-pyrazinetetracarboxylic and related acids [J].
Vishweshwar, P ;
Nangia, A ;
Lynch, VM .
CHEMICAL COMMUNICATIONS, 2001, (02) :179-180
[40]  
Wang ZM, 2000, ANTI-CANCER DRUG DES, V15, P405